Skip to main content
Clinical Trials/RBR-96t463
RBR-96t463Active, not recruiting未知

se of platelet-rich plasma in diabetic patients with dry eye disease.

Hemocentro de Alagoas-HEMOA0 sitesStarted: July 28, 2015Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Active, not recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Intervention

Eligibility Criteria

Ages
18Y to 90Y (—)

Inclusion Criteria

  • Diagnose of diabetes following ADA (American Diabetes Association)criteria;moderate or severe dry eye patients with unresponsiveness or a weak response to conventional treatment; having at least a frequent or constant symptom and either a Schirmer test at less than 15mm or a BUT(Break Up Time test) less than 10 seconds.

Exclusion Criteria

  • Individuals under 18; mentally disabled; pregnant women; indigenous people and those who are wards of the state. Patients that had keratopathies; use of glaucoma eyedrops; previous rheumatic disease diagnosis. Patients that had contraindicated conditions to be submitted to autologous donation

Investigators

Sponsor
Hemocentro de Alagoas-HEMOA

Similar Trials